Zsírmáj (MASLD/MASH): vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 24 Also abroad 367

24 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Where
Newcastle upon Tyne
Életkor
18 év to 75 év
People
360 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07631637 · EU 2026-525916-33-00
3. fázisTaking people
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Where
Birmingham, Cambridge, Liverpool, London, Newcastle upon Tyne
Életkor
18 év to 80 év
People
1650 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06215716
3. fázisNot yet taking people in Egyesült Királyság
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Where
Bradford, Leeds, Leicester, London, Plymouth
Életkor
18 év and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00
3. fázisTaking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Aberdeen, Ashton in Makerfield, Bristol, Camberley, Dagenham, Edgbaston, Birmingham, Edgware, Enfield, London, Exeter, Glasgow, Hull, London, Newcastle upon Tyne, Northwood, Nottingham, Orpington, London, Preston, Rochdale, Sheffield, Southampton, Tooting, London, York
Életkor
18 év and over
People
1800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
3. fázisTaking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Aberdeen, Bristol, Camberley, Derby, Edgbaston, Birmingham, Exeter, Glasgow, Hull, Liverpool, London, Newcastle upon Tyne, Northwood, Orpington, London, Preston, Rochdale, Sheffield, Southampton, Tooting, London, York
Életkor
18 év and over
People
1590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
3. fázisTaking people
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Where
Bristol, Glasgow, High Wycombe, Hull, London, Oxford, Portsmouth, Preston, Southampton, Stockton, Sunderland, Swansea, York
Életkor
18 év to 80 év
People
1350 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Where
Aberdeen, Bristol, Leeds, London, Oxford, Plymouth, Portsmouth, Port Talbot, Southampton
Életkor
18 év to 75 év
People
1800 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00
3. fázisTaking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Birmingham, London, Newcastle upon Tyne, Nottingham, Whitechapel
Életkor
18 év to 80 év
People
2150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
3. fázisTaking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Aberdeen, Clifton, Enfield, Glasgow, Ipswich, Liverpool, London, Newcastle upon Tyne, Oxford, Penzance, Preston, Rochdale, Sheffield, York
Életkor
18 év and over
People
4500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
No phaseTaking people
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
Where
London
Életkor
18 év to 80 év
People
2000
Run by
Richmond Research Institute
See details and how to joinNCT04873258
4. fázisTaking people
Fibrosis Lessens After Metabolic Surgery
Where
Bristol, London
Életkor
18 év to 75 év
People
120 worldwide
Run by
The Cleveland Clinic
See details and how to joinNCT06374875
No phaseTaking people
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
Where
London
Életkor
45 év to 65 év
People
72
Run by
Queen Mary University of London
See details and how to joinNCT07013916
No phaseTaking people
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Where
Nottingham
Életkor
18 év and over
People
45
Run by
University of Nottingham
See details and how to joinNCT07093346
No phaseNot yet taking people in Egyesült Királyság
Temporal Eating Patterns and Metabolic Health
Where
Cambridge
Életkor
18 év to 80 év
People
400
Run by
Maria Chondronikola
See details and how to joinNCT07630636
No phaseTaking people
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
Where
London
Életkor
18 év and over
People
153
Run by
Queen Mary University of London
See details and how to joinNCT04141592
1/2. fázisTaking people
Study of TGM-312-SC01 in Healthy Participants and Adults With MASH
Where
London
Életkor
18 év to 70 év
People
99
Run by
Tangram Therapeutics Plc
See details and how to joinNCT07427680
3. fázisTaking people
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Where
Basildon, Bournemouth, Bristol, Chelmsford, Derby, Dundee, Gateshead, Glasgow, Hull, Inverness, Leeds, London, Newcastle upon Tyne, Newport, Nottingham, Plymouth, Southampton, Torquay
Életkor
18 év and over
People
300
Run by
King's College London
See details and how to joinNCT06461208
No phaseTaking people
Integrated Diagnostics for Early Diagnosis of Liver Disease
Where
Manchester
Életkor
18 év and over
People
1200
Run by
Manchester University NHS Foundation Trust
See details and how to joinNCT04666402
No phaseTaking people
The COherence of Scatter Identification and Exclusion Algorithm Study
Where
London
Életkor
18 év and over
People
15
Run by
Institute of Cancer Research, United Kingdom
See details and how to joinNCT06975579
4. fázisNot yet taking people in Egyesült Királyság
Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Where
London
Életkor
18 év and over
People
100
Run by
St. George's Hospital, London
See details and how to joinNCT06920316
No phaseNot yet taking people in Egyesült Királyság
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
Where
Newcastle upon Tyne
Életkor
18 év and over
People
30 000 worldwide
Run by
Universität des Saarlandes
See details and how to joinNCT06907563
1. fázisTaking people
COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
Where
Oxford
Életkor
18 év and over
People
10
Run by
University of Oxford
See details and how to joinNCT06704516
No phaseTaking people
The European NAFLD Registry
Where
Birmingham, Cambridge, Gateshead, Hull, London, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Portsmouth
Életkor
18 év to 100 év
People
10 000 worldwide
Run by
Newcastle University
See details and how to joinNCT04442334
No phaseTaking people
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
Where
Birmingham, Cambridge
Életkor
Up to 18 év
People
2000 worldwide
Run by
Cambridge University Hospitals NHS Foundation Trust
See details and how to joinNCT04190849